Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Commentary
  • Published:

To be or not to be a proliferation marker?

Oncogene volume 33, pages 954–955 (2014)Cite this article

Subjects

Abstract

Whether it is nobler in the mind to suffer the slings and arrows of outrageous proliferation, or to take arms against stroma, and favor metastasis… This pastiche of Hamlet’s famous monologue illustrates recent reports on the paradoxical functions of well-established proliferation markers such as c-Myc or cyclin A2 that have revealed their ambiguous roles in the control of proliferation and metastasis. On the one hand, overexpression of c-Myc, while stimulating local proliferation, inhibits invasiveness of cancer cells, whereas on the other, downregulation of cyclin A2 leads to increased motility of transformed cells.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

References

  1. Arsic N, Bendris N, Peter M, Begon-Pescia C, Rebouissou C, Gadéa G et al. A novel function for cyclin A2: control of cell invasion via RhoA signaling. J Cell Biol 2012; 196: 147–162.

    Article  CAS  Google Scholar 

  2. Pagano M, Pepperkok R, Verde F, Ansorge W, Draetta G . Cyclin A is required at two points in the human cell cycle. EMBO J 1992; 11: 961–971.

    Article  CAS  Google Scholar 

  3. Lindqvist A, Rodriguez-Bravo V, Medema R . The decision to enter mitosis: feedback and redundancy in the mitotic entry network. J Cell Biol 2009; 185: 193–202.

    Article  CAS  Google Scholar 

  4. Murphy M, Stinnakre MG, Senamaud-Beaufort C, Winston NJ, Sweeney C, Kubelka M et al. Delayed early embryonic lethality following disruption of the murine cyclin A2 gene. Nat Genet 1997; 15: 83–86.

    Article  CAS  Google Scholar 

  5. Kalaszczynska I, Geng Y, Iino T, Mizuno S, Choi Y, Kondratiuk I et al. Cyclin A is redundant in fibroblasts but essential in hematopoietic and embryonic stem cells. Cell 2009; 138: 352–365.

    Article  CAS  Google Scholar 

  6. Liu H, Radisky DC, Yang D, Xu R, Radisky ES, Bissell MJ et al. MYC suppresses cancer metastasis by direct transcriptional silencing of αv and β3 integrin subunits. Nat Cell Biol 2012; 14: 567–574.

    Article  CAS  Google Scholar 

  7. Bissell MJM, Hines WC . Why don’t we get more cancer? A proposed role of the microenvironment in restraining cancer progression. Nat Med 2011; 17: 320–329.

    Article  CAS  Google Scholar 

  8. Lu P, Weaver VM, Werb Z . The extracellular matrix: a dynamic niche in cancer progression. J Cell Biol 2012; 196: 395–408.

    Article  CAS  Google Scholar 

  9. Guo W, Giancotti FG . Integrin signaling during tumour progression. Nat Rev Mol Cell Biol 2004; 5: 816–826.

    Article  CAS  Google Scholar 

  10. Sahai E, Marshall CJ . ROCK and Dia have opposing effects on adherens junctions downstream of Rho. Nat Cell Biol 2002; 4: 408–415.

    Article  CAS  Google Scholar 

  11. Ohtoshi A, Maeda T, Higashi H, Ashizawa S, Yamada M, Hatakeyama M . Beta 3 endonexin as a novel inhibitor of cyclin A-associated kinase. Biochem Biophys Res Commun 2000; 267: 947–952.

    Article  CAS  Google Scholar 

  12. Partanen JI, Nieminen AI, Mäkelä TP, Klefstrom J . Suppression of oncogenic properties of c-Myc by LKB1-controlled epithelial organization. Proc Natl Acad Sci USA 2007; 104: 14694–14699.

    Article  Google Scholar 

  13. Anastasiadis NZ, Moon SY, Thoreson MA, Mariner GJ, Crawford HC, Zheng Y et al. Inhibition of RhoA by p120 catenin. Nat Cell Biol 2000; 2: 637–644.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Robert Hipskind and Daniel Fisher for their kind review of this manuscript.

Author information

Authors and Affiliations

  1. Institut de Génétique Moléculaire de Montpellier, CNRS, Montpellier, France

    J M Blanchard

  2. Université Montpellier 2, Montpellier, France

    J M Blanchard

  3. Université Montpellier 1, Montpellier, France

    J M Blanchard

Authors
  1. J M Blanchard
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J M Blanchard.

Ethics declarations

Competing interests

The author declares no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Blanchard, J. To be or not to be a proliferation marker?. Oncogene 33, 954–955 (2014). https://doi.org/10.1038/onc.2013.19

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/onc.2013.19

This article is cited by

Search

Advanced search

Quick links